Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melike Ozcelik

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Oncology Research and Treatment|April 1, 2016
Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung CancerNur Sener Dinc, Kubra Aydın, Hatice Odabas, et al.
Journal of Clinical Medicine|March 28, 2026
Real-World Outcomes of Neoadjuvant Dual Blockade in HER2-Positive Breast Cancer: The Role of Tumor Biology and pCRAyberk Bayramgil, Mehmet Haluk Yücel, Ezgi Turkoglu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 11, 2015
Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical OncologyMelike Ozcelik, Mesut Seker, Emrah Eraslan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 14, 2016
Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical OncologyOzlem Ercelep, Turkan Ozturk Topcu, Ibrahim Vedat Bayoglu, et al.
Tumori|August 9, 2021
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world studyIbrahim Cil, Ahmet Kucukarda, Muhammed Mustafa Atcı, et al.
Oncology|June 28, 2023
Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated SurgicallyMurat Bardakci, Derya Demirtas Esmer, Emre Hafizoglu, et al.
Clinical Colorectal Cancer|September 28, 2016
Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative ResectionDincer Aydin, Mehmet Ali Sendur, Umut Kefeli, et al.
Future Oncology (London, England)|January 27, 2022
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort studyAyse Irem Yasin, Sabin Göktas Aydin, Bilge Sümbül, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 13, 2024
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRCMahmut Emre Yildirim, Nuri Karadurmuş, İlker Nihat Ökten, et al.
Journal of Clinical Medicine|August 28, 2025
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)Ali Kalem, Tulay Kus, Savas Gokcek, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Oncology Research and Treatment|April 1, 2016
Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung CancerNur Sener Dinc, Kubra Aydın, Hatice Odabas, et al.
Journal of Clinical Medicine|March 28, 2026
Real-World Outcomes of Neoadjuvant Dual Blockade in HER2-Positive Breast Cancer: The Role of Tumor Biology and pCRAyberk Bayramgil, Mehmet Haluk Yücel, Ezgi Turkoglu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 11, 2015
Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical OncologyMelike Ozcelik, Mesut Seker, Emrah Eraslan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 14, 2016
Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical OncologyOzlem Ercelep, Turkan Ozturk Topcu, Ibrahim Vedat Bayoglu, et al.
Tumori|August 9, 2021
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world studyIbrahim Cil, Ahmet Kucukarda, Muhammed Mustafa Atcı, et al.
Oncology|June 28, 2023
Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated SurgicallyMurat Bardakci, Derya Demirtas Esmer, Emre Hafizoglu, et al.
Clinical Colorectal Cancer|September 28, 2016
Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative ResectionDincer Aydin, Mehmet Ali Sendur, Umut Kefeli, et al.
Future Oncology (London, England)|January 27, 2022
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort studyAyse Irem Yasin, Sabin Göktas Aydin, Bilge Sümbül, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 13, 2024
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRCMahmut Emre Yildirim, Nuri Karadurmuş, İlker Nihat Ökten, et al.
Journal of Clinical Medicine|August 28, 2025
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)Ali Kalem, Tulay Kus, Savas Gokcek, et al.
Pageof 4